A total of 71,767 patients were included: median age was 4.6 years, 61.4% were white, and 49.3% had public insurance; 33.5% received SAP. Of these participants, 996/71,767 (1.4%) had a perioperative allergic reaction and <0.1% were diagnosed with an SSI. On mixed effects logistic regression, those who received SAP had 1.2 times the odds of a perioperative allergic reaction compared with those who did not receive SAP (P=0.005). Surgical antibiotic prophylaxis was not associated with decreased rates of SSI, lower hospital readmission, nor a lower chance of a repeat encounter within 30 days.
Objective: It was hypothesized that children who received SAP prior to orchiopexy would have no reduction in surgical site infection (SSI) risk but an increased risk of antibiotic-associated adverse events.
Methods: A retrospective cohort study was conducted of all males aged between 30 days and 18 years who underwent an orchiopexy (ICD-9 CM 62.5) in an ambulatory or observation setting from 2004-2015 using the Pediatric Health Information System database. Inpatients and those with concomitant procedures were excluded. Chi-squared or Fisher's exact tests were used to determine the association between SAP and allergic reaction (defined as a charge for epinephrine or ICD-9 diagnosis code for allergic reaction on the date of surgery) and any of the following within 30 days: SSI, hospital readmission or any repeat hospital encounter. Mixed effects logistic regression was performed, controlling for age, race, and insurance, and clustering of similar practice patterns by hospital. 
Introduction
Surgical antibiotic prophylaxis (SAP) refers to the use of perioperative antimicrobial agents to prevent surgical site infections (SSI). In adult urologic surgery, there is universal support for this practice for clean contaminated procedures, contaminated procedures, and dirty procedures.
American Urological Association (AUA) guidelines recommend the routine use of SAP only in clean procedures where associated risk factors are present. European guidelines do not routinely recommend their use for clean procedures [1] [2] [3] . The variation in appropriate use of SAP in both pediatric and adult populations highlights the ambiguity of this topic [4] [5] [6] [7] [8] [9] . Decisions about SAP use in the pediatric population are complicated by the lack of guidelines. Several animal and human studies have demonstrated the benefits of perioperative antibiotic prophylaxis [10] [11] [12] [13] . However, a recent study of pediatric urology patients demonstrated a very low rate of postoperative infection (0.8%) across all wound classifications and surgical sites [14] .
There was no demonstrable difference in SSI for clean procedures with or without SAP, with most SSI occurring in the clean-contaminated surgeries (which universally received SAP). They also noted no antibiotic-related adverse events. Given the low rates of SSI (especially with clean procedures) and lack of adverse events, the authors suggested focusing upon clean-contaminated procedures for future recommendations and studies [14] .
Multiple recent studies of pediatric surgery patients have demonstrated that children who received SAP were at a significantly increased risk of receiving epinephrine (a surrogate for allergic reaction) and Clostridium difficile (C. difficile) infection compared with those who did not receive SAP [4, 15] . Macy et al. demonstrated in a retrospective analysis that cephalosporins
led to an increased risk of C. difficile infection, anaphylaxis, nephropathy (0.15%) and all-cause mortality within 1 day (0.10%) [16] . Wang et al. linked acetaminophen and/or antibiotic exposure within the first year of life with certain lifelong diseases, including atopic dermatitis, asthma, and allergic rhinitis [17] . Multiple studies have documented cephalosporin crossreactivity with other ß-lactam antibiotics, and the ß-lactam family is the most common cause of hypersensitivity drug reactions [18, 19] . From a population health standpoint, the inappropriate use of antibiotics inevitably results in the selection of resistant organisms in the community, leading to future morbidity and healthcare costs, especially with respect to methicillin-resistant [20] [21] [22] [23] . A previous study showed that SAP given during pediatric circumcision had no association with SSI, penile reoperation, or hospital visit on bivariate analysis, but did lead to an increased risk of allergic reaction or hospital visit on multivariate analysis [24] .
Staphylococcus aureus infections in infants
The current study sought to evaluate, using the Pediatric Health Information System (PHIS) database, the effect of SAP at the time of orchiopexy on rates of SSI, readmission, reoperation, and antibiotic-associated adverse events. It was hypothesized that children who received SAP prior to outpatient orchiopexy would have no reduction in SSI risk, but an increased risk of antibiotic-associated adverse events (AAAE). 
Study population
A retrospective cohort study was performed of all males aged between 30 days and 18 years who underwent an orchiopexy (ICD-9-CM 62.5) with or without herniorraphy (ICD-9-CM 53.0-53.1) in an ambulatory or observation setting from January 2004 to December 2015. Patients admitted for observation were included to avoid missing patients whose status changed from ambulatory to observation due to an intra-operative adverse event such as a perioperative allergic reaction M A N U S C R I P T A C C E P T E D 6 (PAR). Of note, a patient was categorized as having received SAP if a charge was found on the day of surgery for an antibiotic. It was assumed that patients with SAP charges received the medication. The authors felt confident in the validity of the PHIS pharmacy charges, based on the validation study by Chan et al. [25] . Inpatients and those who had length of stay >2 days were excluded, as were cases with concurrent procedures, to ensure that the use of SAP was associated with orchiopexy alone (Fig. 1 ). The cohorts that did and did not receive SAP were then compared.
Calculation of antibiotic-associated adverse event rates
To characterize the incidence of PAR associated with the administration of SAP, the algorithm 
Results
A total of 91,919 males who underwent orchiopexy in an ambulatory or observation setting during the study period were identified. Of these, 20,243 who underwent concurrent procedures (other than hernia repair) were excluded, leaving 71,676 patients for analysis. Of these patients, 33 .5% (23,986) were given SAP and 66.5% (47,690) were not ( Fig. 1) .
Patient characteristics are shown in Table 1 . The median age and mean age was 3 years and 4. On mixed effects logistic regression, patients who received SAP had a 21% increased risk of a PAR compared to those who did not receive SAP (OR 1.21, 95% CI 1.06-1.38, P=0.005). The SAP group did not significantly differ in the rate of immediate allergic reaction (during encounter) (P=0.438), SSI within 30 days (P=0.385), hospital admission (0.379), or 30-day repeat encounter of any kind (P=0.065) ( Table 2 ).
The study then examined how the relative proportion of patients with orchiopexies who received SAP changed over time (Fig. 2) . This rate increased over the course of the study from approximately 20% to 40% of all cases (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) , with an R 2 value of 0.36549. Of note, during the study period, hospitals joined the PHIS data set. To control for any inter-hospital variation, a mixed effects model was used. Thus, for the model-based comparisons, there should have not been any confounding hospital variation.
Lastly, the study sought to access the degree of inter-hospital variability of SAP use for orchiopexy, and this was quite variable, ranging from 3-88% of all orchiopexy cases performed at an individual hospital (Fig. 3 ).
Discussion
Of nearly 71,000 patients undergoing orchiopexy, with or without herniorrhaphy, it was found that SAP did not reduce the risk of postoperative surgical site infection, readmission, or repeat encounter, but it did significantly increase the risk of PAR. Interestingly, when divided into subgroups based upon age, those aged >1 year were just as unlikely to have an infection (95% CI crossed 1) ( Table 2) .
A previous study demonstrated that SAP provided no benefit in pediatric circumcisions, with a clear increased risk of adverse events [24] . Previous studies have also suggested the safety of eliminating SAP in pediatric hernia repair and orchiopexy; however, relatively small cohorts of patients and rare incidence of postoperative surgical site require a large patient cohort to determine if a true benefit (or detriment) exists [27] . There is also evidence in the adult literature that SAP does not decrease the risk in certain clean procedures, including microsurgical varicocelectomy, adrenalectomy, partial nephrectomy, and nephrectomy [28, 29] . Other studies have demonstrated that topical antibiotic prophylaxis may be more beneficial in adult microsurgical varicocelectomies (a clean, adult operation somewhat analogous to pediatric orchiopexy) [30] .
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The current study also discovered an increased risk of an array of adverse events associated with SAP. Immediate allergic reaction was found to have an OR of 1.21 in the group given SAP, as defined by the use of epinephrine or diphenhydramine or use of any of the previously stated ICD-9 diagnosis codes for a drug reaction during the surgical encounter (Appendix 1).
As mentioned in previous studies, a lack of evidence-based guidelines regarding SAP for this common procedure has lead to significant variability in the use of SAP. This finding has been demonstrated with other clean and clean-contaminated procedures in pediatrics, such as circumcision, inguinal hernia repair, hydrocele repair, laparoscopic varicocelectomy, hypospadias repair, and endoscopic urological procedures, and spinal procedures [5, 31] . Of further interest in a study by Chan et al., those using SAP for clean procedures had a higher likelihood of using SAP for clean-contaminated procedures. In contrast, those not using SAP for clean-contaminated procedures, had a higher likelihood of not using SAP for clean procedures either.
The most recent AUA Best Practice Policy Statement recommends SAP for clean-contaminated, adult, urologic procedures, and none for clean procedures, unless there are 'risk factors' [1] . A multi-society guideline also recommends not using SAP for clean pediatric procedures [32] .
European guidelines have proposed similar recommendations. To address growing concerns of drug-resistant strains of bacteria, some have called for a renewed focus on antibiotic stewardship, especially in the treatment of children [33, 34] .
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The increasing use of perioperative antibiotics can only be speculated (Fig. 2) . It is possible that 'minor' surgery has increasingly been performed at outpatient surgery centers. With an interest in efficiency, these centers may lean toward requiring or 'encouraging' perioperative antibiotics for all surgeries/procedures as a 'quality measure'; however, this can only be speculated.
This study had some important strengths. By using the PHIS database, it was able to develop a large cohort of patients. This allowed relatively rare outcomes to be studied (e.g. immediate allergic reactions). By collecting patients throughout the US, and by modeling hospitals as random effects, it was able to minimize bias related to particular centers or local patient populations. It also studied a relatively common surgical procedure that is relatively commonly performed by pediatric urologists (and pediatric surgeons).
There were also notable limitations to this study. The most important were those related to the collection of administrative data. With this data set, the study was reliant upon the veracity of the 43 reporting institutions' billing and diagnosis documentation. To ensure accuracy, the Children's Hospital Association reviews PHIS data for accuracy on a quarterly basis. As with all relatively large data sets, there is a certain limit to the level of granularity. Similarly, the study could not capture data related to postoperative course at geographically local primary care offices or emergency rooms. Also, given the inclusion of only free-standing, non-for-profit, US children's hospitals, those treated at other institutions were not captured. In addition, it was unable to access any outpatient physician records (clinic, telephone, or other) to verify the lack of AEs (SSI or otherwise). Theoretically, it could have underestimated the rate of AEs in both groups. Given the relatively broad definition of an allergic reaction, it could also have M A N U S C R I P T A C C E P T E D 12 overestimated the true incidence. Epinephrine and diphenhydramine use could have been for a number of reasons, including allergy to any other agent received during the surgical encounter.
Without antigen challenge test results any 'true' allergic reaction cannot be confirmed. However, this method has been utilized in previous studies [16] . Lastly, given that only those treated through a general outpatient setting (no inpatient stays >2 days) and without concurrent surgical procedures, the patient population likely excluded a small minority of patients with significant medical morbidities.
Conclusion
This study found convincing evidence to suggest that SAP for pediatric orchiopexy has no clear benefit in the prevention of SSI. In addition, it demonstrated a statistically significant increased risk of immediate allergic reaction. Given these findings, the current institution has decided to limit antibiotic use for SAP for orchiopexy. Further study in other pediatric urology surgeries is invited to further elucidate the benefits and risks associated with SAP for pediatric patients. 
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